ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma

INTRODUCTION: ARTEMIN (ARTN) is an estrogen regulated growth factor, the expression of which promotes resistance to antiestrogen therapies and predicts poorer survival outcome of patients with estrogen receptor (ER) positive mammary carcinoma (ER+MC) treated with tamoxifen. ARTN is also expressed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerjee, Arindam, Wu, Zheng-Sheng, Qian, PengXu, Kang, Jian, Pandey, Vijay, Liu, Dong-Xu, Zhu, Tao, Lobie, Peter E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326554/
https://www.ncbi.nlm.nih.gov/pubmed/22060274
http://dx.doi.org/10.1186/bcr3054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326554/
https://www.ncbi.nlm.nih.gov/pubmed/22060274
http://dx.doi.org/10.1186/bcr3054

Ejemplares similares